Malignant melanoma developed on a congenital melanocytic nevus with lymph node metastasis in a 19-month-old boy

Turkish Journal of Pediatrics

Volumn 54, Issue 4, 2012, Pages 432-435

  Özkan, Özlenen ^a   Cinpolat, Ani ^b   Bektaş, Gamze ^c   Özkan, Ömer ^a  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Adana Numune Training and Research Hospital   (Turkey)

^c Tatvan State Hospital   (Turkey)

Author keywords

Congenital melanocytic nevus; Malignant melanoma; Pediatric melanoma

Indexed keywords

ALPHA2B INTERFERON;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CHILD; FACIAL NERVE PARALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MELANOCYTIC NEVUS; MELANOMA; NECK DISSECTION; PAROTIDECTOMY; PRESCHOOL CHILD; SENTINEL LYMPH NODE BIOPSY; SKIN SCAR; SKIN SURGERY;

HUMANS; INFANT; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASM STAGING; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 84873829676     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Geller E. Infantile melanoma-a triple threat: diagnosis and management. Ann Plast Surg 2011; 67: 85-89.
2. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N Engl J Med 1995; 332: 656-662.
3. Krengel S, Hauschild A, Schafer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 2006; 155: 1-8.
4. Richardson SK, Tannous ZS, Mihm MC. Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. J Am Acad Dermatol 2002; 47: 77-90.
5. Greenley PW. Incidence of malignancy in giant pigmented nevi. Plast Reconstr Surg 1965; 36: 26-37.
6. Ka VS, Dusza SW, Halpern AC, Marghoob AA. The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an internet-based registry of 379 patients. Melanoma Res 2005; 15: 61-67.
7. Kaplan EN. The risk of malignancy in large congenital nevi. Plast Reconstr Surg 1974; 53: 421-428.
8. Pappo AS. Melanoma in children and adolescents. Eur J Cancer 2003; 39: 2651-2661.
9. Gibbs P, Moore A, Robinson W, Walsh P, Golitz L, Gonzalez R. Pediatric melanoma: are recent advances in the management of adult melanoma relevant to the pediatric population. J Pediatr Hematol Oncol 2000; 22: 428-432.
10. Shah NC, Gerstle JT, Stuart M, Winter C, Pappo A. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience. J Pediatr Hematol Oncol 2006; 28: 496-500.
11. Makkar HS, Frieden IJ. Congenital melanocytic nevi: an update for the pediatrician. Curr Opin Pediatr 2002; 14: 397-403.
12. Urist MM, Soong S-J. Melanoma and cutaneous malignancies. In: Townsend CM, Mattox KM, Evers BM, Beauchamp RD (eds). Sabiston Textbook of Surgery (17th ed). Philadelphia: Saunders; 2004: 781-802.
13. Zuckerman R, Maier J P, Guiney WB, Huntsman WT, Mooney EK. Pediatric melanoma: confirming the diagnosis with sentinel node biopsy. Ann Plast Surg 2001; 46: 394-399.
14. Gershenwald JE, Thompson W, Mansfield P F, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I and II melanoma patients. J Clin Oncol 1999; 17: 976-983.
15. Trozak DJ, Rowland WD, Hu F. Metastatic melanoma in prepubertal children. Pediatrics 1975; 55: 191-204.
16. Flaherty LE, Thompson JA, Tuthill RJ. Phase III trial of high dose interferon alfa-2b versus cisplatin, vinblastine, DTIC plus IL-2 and interferon in patients with high risk melanoma (SWOG S0008). American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), published oral presentation.
17. Zapas JL, Coley HC, Beam SL, Brown SD, Jablonski KA, Elias EG. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. J Am Coll Surg 2003; 197: 403-407.
18. Balch CM, Soong S, Barolucci AA. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224: 255-266.
19. Pacella SJ, Lowe L, Bradford C, Marcus BC, Johnson T, Rees R. The utility of sentinel lymph node biopsy in head and neck melanoma in the pediatric population. Plast Reconstr Surg 2003; 112: 1257-1265.
20. Berg P, Lindelof B. Differences in malignant melanoma between children and adolescents. Arch Dermatol 1997; 133: 295-297.
21. Jafarian F, Hatami A, Kokta V, et al. Malignant melanoma in children and adolescents: review of 13 cases. Pediatr Dermatol 2004; 21: 394.
22. Wu SJ, Lambert DR. Melanoma in children and adolescents. Pediatr Dermatol 1997; 14: 87-92.
23. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14: 7-17.
24. Anderson C, Buzaid A, Legha S. Systemic treatment of advanced cutaneous melanoma. Oncology 1995; 9: 1149-1158.
25. Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889-897.